E

    Exscientia

    AI-driven pharma tech company specializing in precision medicine and automated drug design.

    GBUnited Kingdom
    Headquarters
    🇬🇧United Kingdom
    Data Hosting
    EU-based
    Structure
    Independent
    Compliance
    ▣GDPR◆EU HQ

    Exscientia key facts

    Last updated
    Legal entity
    Exscientia plc
    Headquarters
    United Kingdom (GB)
    Ownership
    Independent
    Deployment
    SaaS
    Open source
    No
    US Cloud Act exposure
    Exposed
    Replaces
    Recursion, Schrödinger, Inc, Insilico Medicine

    About Exscientia

    Exscientia is a technology-driven biopharmaceutical company that uses artificial intelligence to design and develop new medicines. The company integrates AI with experimental biology to automate the drug discovery process, aiming to deliver higher-quality drug candidates more rapidly than traditional methods. Their platform spans the entire development lifecycle, from identifying biological targets to designing molecules and predicting patient responses in clinical trials.\n\nThe company's 'Patient-First' approach utilizes primary human tissue samples to provide data for its AI models, ensuring that the discovered medicines are optimized for actual human biology rather than animal models alone. This end-to-end integration is designed to increase the success rate of clinical trials and provide tailored treatments for specific patient populations.

    Alternative to

    Target Segments

    EnterpriseOther

    Deployment Options

    SaaS

    Key Features

    Patient-First AI platform
    Precision Target identification
    Precision Design for drug candidate optimization
    Precision Experimentation using cellular imaging
    Precision Medicine development pipeline
    AI models trained on cellular imaging data

    Related Articles

    All articles